Before taking this quiz, make sure to listen to our podcast with Dr Stefan Holubar here.
The type of prior malignancy that is most often discussed in inflammatory bowel disease (IBD) management is:
Individuals with ulcerative colitis (UC) have a dramatically higher risk for developing colorectal cancer than individuals with Crohn disease.
When treating IBD, 6-mercaptopurine (6-MP) is not a good choice for certain groups of young men and which other patient population?
A combination therapy of a biologic and immunomodulator thiopurine can increase the risk of lymphoma.
When managing IBD in someone with or who has had a malignancy, besides a gastroenterologist, the team should include: